ERBB2 and breast carcinoma: Although molecular profiling of breast tumours has provided valuable insights into the biological behaviour of different subtypes of breast cancer, in the clinical/pathology setting classification of breast cancer is routinely based on IHC staining for ERα, PR and HER2.